Insider sales are routine post-vesting liquidity events — no bearish signal. Monitor EDG-7500 Phase 3 initiation in Q4 2026 as the primary catalyst. The $2.01B pro-forma cash position provides a multi-year runway; the Q2 miss is noise for a pre-revenue biotech.
Price Chart
Executive Summary
CEO Kevin Koch and General Counsel John Moore sold a combined ~$468K in open-market sales on August 12, 2026, following the Q2 earnings miss and the close of the sevasemten sale to Servier. The sales are small relative to the $4.8B market cap (~0.01%) and are paired with large non-cash equity grants and derivative exercises, suggesting tax-related selling rather than a bearish signal. The cluster is neutral — the dollar value is trivial and the sales are likely liquidity-driven post-vesting.
Key Financial Metrics
Key Facts
- CEO Kevin Koch sold 18,000 shares for ~$785K total (two trades on Aug 12 at ~$43.64-$44.33)
- General Counsel John Moore sold 5,016 shares for ~$220K total (four trades on Aug 12 at ~$43.80-$44.50)
- Both executives received large non-cash equity grants (Koch: 300,000 shares; Moore: 97,500 shares) on the same day
- Total open-market sales of ~$1.0M represent ~0.02% of $4.8B market cap — well below materiality threshold
- Q2 2026 net loss of -$0.53/share missed consensus by 12.2%; company completed sevasemten sale for $1.55B upfront
- Company pivoting to pure-play cardiovascular focus with EDG-7500 Phase 3 start planned Q4 2026
Financial Impact
Total insider open-market sales of ~$1.0M, or ~0.02% of market cap — immaterial
Risk Factors
- Pre-revenue company with widening operating losses as it funds cardiovascular pipeline
- EDG-7500 Phase 3 data risk — no approved products
- Potential further dilution if cash burn accelerates before revenue generation
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-EWTX-1786774555208 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 7w ago | Insider Cluster | $44.17 $44.62 | ▲ +1.02% | ▲ +3.01% | $41.22 (−6.68%) |
Aug 14, 2026 7w ago | Insider Cluster | $44.17 $44.62 | ▲ +1.02% | ▲ +3.01% | $41.22 (−6.68%) |
Aug 6, 2026 8w ago | 8-K | $44.42 $41.95 | ▼ −5.56% | ▼ −6.16% | $41.22 (−7.20%) |
Jul 13, 2026 11w ago | 8-K | $41.27 $44.58 | ▲ +8.02% | ▲ +4.84% | $41.22 (−0.12%) |
Jun 1, 2026 17w ago | 8-K | $40.26 $40.63 | ▲ +0.92% | ▲ +2.22% | $41.22 (+2.38%) |
May 7, 2026 21w ago | 8-K | $35.58 $36.21 | ▲ +1.77% | ▼ −1.37% | $41.22 (+15.85%) |
Apr 23, 2026 23w ago | DEFA14A | $31.58 $32.69 | ▲ +3.51% | ▼ −0.51% | $41.22 (+30.53%) |
Mar 27, 2026 26w ago | 144 | $30.28 $30.99 | ▲ +2.34% | ▼ −10.25% | $41.22 (+36.13%) |
Feb 26, 2026 31w ago | 8-K | $29.66 $31.65 | ▲ +6.71% | ▲ +13.11% | $41.22 (+38.98%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access